2026-2034年全球口腔黏膜注射系統市場規模、佔有率、趨勢和成長分析報告

預計口腔黏膜給藥系統的市場規模將從 2025 年的 53 億美元成長到 2034 年的 93.6 億美元，並預計從 2026 年到 2034 年將以 6.54% 的複合年成長率成長。

隨著製藥公司尋求新的給藥途徑以提高患者依從性和治療效果，全球口腔給藥系統市場正日益受到關注。口腔給藥系統透過臉頰內側黏膜輸送藥物，繞過消化器官系統，進而實現藥物的快速吸收。這種方法尤其適用於需要快速起效或難以透過胃腸道吸收的藥物。

對非侵入性給藥技術日益成長的需求是推動市場成長的主要動力。口腔給藥系統相比傳統口服藥物具有許多優勢，包括給藥方便、生物利用度更高、副作用更少。製藥公司正加大研發投入，致力於開發先進的口腔製劑，例如薄膜、片劑和凝膠，以提高藥物的穩定性和療效。

隨著醫療服務提供者和患者對便利高效治療方法的需求日益成長，全球口腔黏膜給藥系統市場預計將持續擴張。製劑技術的不斷進步推動了創新給藥平台的開發。隨著人們對更人性化的給藥方式和更好治療效果的日益關注，口腔黏膜給藥市場預計將繼續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球頰黏膜注射系統市場：依類型分類

• 市場分析、洞察與預測
• 舌下膜/舌下片
• 頰黏膜片劑/錠劑
• 口腔噴霧劑

第5章：全球口腔黏膜給藥系統市場：依應用分類

• 市場分析、洞察與預測
• 疼痛管理
• 禁止抽煙
• 心絞痛
• 其他

第6章：全球頰黏膜注射系統市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診部
• 其他（診所、居家醫療/非處方藥）

第7章：全球頰黏膜注射系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • GSK Plc
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Generex Biotechnology Corporation（LUMITOS AG）
  • ARx LLC
  • Endo Inc
  • Catalent Inc
  • Cynapsus Therapeutics Inc
  • Collegium Pharmaceutical
  • Indivior PLC

The Buccal Drug Delivery System Market size is expected to reach USD 9.36 Billion in 2034 from USD 5.30 Billion (2025) growing at a CAGR of 6.54% during 2026-2034.

The Global Buccal Drug Delivery System Market is gaining traction as pharmaceutical companies explore alternative drug administration methods that improve patient compliance and therapeutic effectiveness. Buccal drug delivery systems allow medications to be absorbed through the lining of the cheek, providing rapid drug absorption and bypassing the digestive system. This method is particularly beneficial for drugs that require quick action or have poor gastrointestinal absorption.

The growing demand for non-invasive drug delivery technologies is a key driver of market growth. Buccal drug delivery systems offer advantages such as ease of administration, improved bioavailability, and reduced side effects compared to traditional oral medications. Pharmaceutical companies are investing in research to develop advanced buccal formulations, including films, tablets, and gels that enhance drug stability and effectiveness.

Looking forward, the Global Buccal Drug Delivery System Market is expected to expand as healthcare providers and patients increasingly prefer convenient and efficient treatment options. Ongoing advancements in pharmaceutical formulation technologies are enabling the development of innovative drug delivery platforms. With rising interest in patient-friendly medication methods and improved therapeutic outcomes, the buccal drug delivery market is poised for continued growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Sublingual Films and Wafers
• Buccal Tablets/Lozenges
• Oral Sprays

By Application

• Pain Management
• Smoking Cessation
• Angina Pectoris
• Others

By End-use

• Hospitals
• Ambulatory Centers
• Others (Clinics, Home Health/OTC)

COMPANIES PROFILED

• GSK plc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Generex Biotechnology Corporation LUMITOS AG, ARx LLC, Endo Inc, Catalent Inc, Cynapsus Therapeutics Inc, Collegium Pharmaceutical, Indivior PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Sublingual Films and Wafers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Buccal Tablets/Lozenges Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Oral Sprays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Smoking Cessation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Angina Pectoris Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others (Clinics, Home Health/OTC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BUCCAL DRUG DELIVERY SYSTEM INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GSK Plc
  • 9.2.2 Teva Pharmaceutical Industries Ltd
  • 9.2.3 Pfizer Inc
  • 9.2.4 Generex Biotechnology Corporation (LUMITOS AG)
  • 9.2.5 ARx LLC
  • 9.2.6 Endo Inc
  • 9.2.7 Catalent Inc
  • 9.2.8 Cynapsus Therapeutics Inc
  • 9.2.9 Collegium Pharmaceutical
  • 9.2.10 Indivior PLC